@ARTICLE{
author={Magro F,Tilg H,Cataldi F,Jacobstein D,Rabbat C,Shan K,Nancey S,Markovic S,Rocco R,Harlacher L,Yarur A},
year={2026},
title={Impact of age of subjects on the efficacy and safety of once-daily oral obefazimod in moderately to severely active ulcerative colitis: week 8 results from the ABTECT-1 and ABTECT-2 Phase 3, double-blind, placebo-controlled induction trials},
journal={JOURNAL OF CROHNS & COLITIS},
volume={20},
number={},
pages={-},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Magro F,...,Vucicevic Katarina M,(broj koautora 24)},
year={2024},
title={The influence of persistent organ damage on IFX pharmacokinetic modeling and disease progression assessment: findings from a prospective real-world study in inflammatory bowel disease patients},
journal={JOURNAL OF CROHNS & COLITIS},
volume={18},
number={},
pages={i883-i884},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Magro F,...,Vucicevic Katarina M,(broj koautora 24)},
year={2024},
title={The influence of persistent organ damage on IFX pharmacokinetic modeling and disease progression assessment: findings from a prospective real-world study in inflammatory bowel disease patients},
journal={JOURNAL OF CROHNS & COLITIS},
volume={18},
number={},
pages={I875-I876},
document_type={Meeting Abstract},
}